Table 2.
Resistance Rates of Urine K. pneumoniae Isolates with Diverse Characteristics to Antimicrobial Agents
| Antibiotics | ESBL(+)-KPN | ESBL(-)-KPN | CR-KPN | CSE-KPN | ||||
|---|---|---|---|---|---|---|---|---|
| R (%) | S (%) | R (%) | S (%) | R (%) | S (%) | R (%) | S (%) | |
| SAM | 85.3 (480/563) | 2.8 (16/563) | 34.5 (268/777) | 60.6 (471/777) | 100.0 (122/122) | 0 (0/122) | 50.8 (599/1180) | 40.6 (480/1180) |
| TZP | 6.6 (41/617) | 83.6 (516/617) | 13.6 (120/884) | 82.4 (728/884) | 79.2 (118/149) | 9.4 (14/149) | 3.2 (42/1314) | 91.2 (1198/1314) |
| CAZ | 43.6 (269/617) | 50.2 (310/617) | 18.3 (162/885) | 80.5 (712/885) | 96.6 (144/149) | 3.4 (5/149) | 20.5 (269/1314) | 75.9 (997/1314) |
| CRO | 95.8 (591/617) | 3.4 (21/617) | 17.8 (158/886) | 81.6 (723/886) | 98.7 (147/149) | 1.3 (2/149) | 44.3 (583/1316) | 55.1 (725/1316) |
| FEP | 25.6 (158/617) | 70.5 (435/617) | 12.2 (108/885) | 86.9 (769/885) | 85.9 (128/149) | 8.7 (13/149) | 10.3 (135/1314) | 88.1 (1158/1314) |
| CTT | 1.8 (10/563) | 96.4 (543/563) | 11.7 (91/777) | 86.5 (672/777) | 76.2 (93/122) | 14.8 (18/122) | 0.5 (6/1180) | 98.6 (1163/1180) |
| FOX | 22.9 (64/279) | 71.3 (199/279) | 25.8 (138/534) | 71.2 (380/534) | 99.1 (111/112) | 0.9 (1/112) | 12.8 (85/664) | 82.8 (550/664) |
| ATM | 62.6 (382/610) | 35.7 (218/610) | 15.0 (131/872) | 84.5 (737/872) | 92.3 (132/143) | 7.0 (10/143) | 28.0 (364/1300) | 71.0 (923/1300) |
| ETP | 4.2 (26/615) | 94.6 (582/615) | 13.5 (119/880) | 85.8 (755/880) | 100.0 (149/149) | 0 (0/149) | 0 (0/1316) | 100.0 (1316/1316) |
| IPM | 0.6 (4/617) | 98.9 (610/617) | 11.5 (102/886) | 88.0 (780/886) | 71.8 (107/149) | 22.8 (34/149) | 0 (0/1316) | 100.0 (1316/1316) |
| MEM | 1.4 (4/287) | 97.2 (279/287) | 16.2 (90/557) | 83.5 (465/557) | 80.0 (92/115) | 15.7 (18/115) | 0 (0/686) | 100 (686/686) |
| AMK | 8.2 (49/597) | 91.6 (547/597) | 12.2 (106/868) | 87.8 (762/868) | 66.9 (97/145) | 33.1 (48/145) | 4.3 (55/1284) | 95.6 (1228/1284) |
| GEN | 64.8 (378/583) | 34.1 (199/583) | 23.0 (190/826) | 76.3 (630/826) | 76.3 (100/131) | 22.9 (30/131) | 36.5 (451/1235) | 62.9 (777/1235) |
| TOB | 26.3 (148/563) | 29.3 (165/563) | 16.1 (125/777) | 71.9 (559/777) | 76.2 (93/122) | 10.7 (13/122) | 14.6 (172/1180) | 58.8 (694/1180) |
| CIP | 51.1 (313/613) | 40.6 (249/613) | 27.5 (241/876) | 70.2 (615/876) | 91.7 (133/145) | 6.9 (10/145) | 30.7 (400/1305) | 64.2 (838/1305) |
| LVX | 38.9 (240/617) | 54.0 (333/617) | 24.1 (213/884) | 73.0 (645/884) | 87.2 (130/149) | 11.4 (17/149) | 23.2 (305/1314) | 71.6 (941/1314) |
| SXT | 80.4 (456/567) | 19.6 (111/567) | 32.8 (277/846) | 67.2 (569/846) | 60.6 (87/143) | 39.4 (56/143) | 51.0 (630/1236) | 49.0 (606/1236) |
Abbreviations: ESBL(+)-KPN, ESBL-producing K. pneumoniae; ESBL(-)-KPN, non ESBL-producing K. pneumoniae; CR-KPN, carbapenem-resistant K. pneumoniae; CS-KPN, carbapenem-sensitive K. pneumoniae; SAM, ampicillin/sulbactam; TZP, piperacillin/tazobactam; CAZ, ceftazidime; CRO, ceftriaxone; FEP, cefepime; CTT, cefotetan; FOX, cefoxitin; ATM, aztreonam; ETP, ertapenem; IPM, imipenem; MEM, meropenem; AMK, amikacin; GEN, gentamicin; TOB, tobramycin; CIP, ciprofloxacin; LVX, levofloxacin; SXT, sulfamethoxazole/trimethoprim.